We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$5.97M
2
FISV
Fiserv Inc
FISV
+$5.03M
3
GPC icon
Genuine Parts
GPC
+$4.22M
4
TRI icon
Thomson Reuters
TRI
+$4.1M
5
VGR
Vector Group Ltd.
VGR
+$4.09M

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HGBL icon
1551
Heritage Global
HGBL
$36.8M
$71K 0.01%
28,670
+18,480
+181% +$44.6K
HOOK
1552
DELISTED
HOOKIPA Pharma
HOOK
$71K 0.01%
+11,964
New +$94.9K
MNTK icon
1553
Montauk Renewables
MNTK
$255M
$71K 0.01%
12,502
-3,393
-21% -$15.7K
ABCL icon
1554
AbCellera Biologics
ABCL
$2.12B
$66K ﹤0.01%
22,163
-63,957
-74% -$242K
CMPX icon
1555
Compass Therapeutics
CMPX
$387M
$66K ﹤0.01%
+65,922
New +$96.3K
GTHX
1556
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$66K ﹤0.01%
28,729
+17,955
+167% +$68.6K
AMBP icon
1557
Ardagh Metal Packaging
AMBP
$3.01B
$65K ﹤0.01%
+18,983
New +$71.4K
VLN icon
1558
Valens Semiconductor
VLN
$188M
$64K ﹤0.01%
19,937
-45,755
-70% -$122K
BLNK icon
1559
Blink Charging
BLNK
$87.9M
$58K ﹤0.01%
+21,096
New +$60.2K
LVO icon
1560
LiveOne
LVO
$58.2M
$58K ﹤0.01%
3,698
+2,353
+175% +$41.6K
AQST icon
1561
Aquestive Therapeutics
AQST
$494M
$57K ﹤0.01%
+21,928
New +$73.2K
NDLS icon
1562
Noodles & Co
NDLS
$107M
$55K ﹤0.01%
4,324
-22,692
-84% -$324K
ALDX icon
1563
Aldeyra Therapeutics
ALDX
$93.5M
$53K ﹤0.01%
16,020
-9,229
-37% -$36.1K
APLT
1564
DELISTED
Applied Therapeutics
APLT
$51K ﹤0.01%
10,917
-10,514
-49% -$49.8K
BTM
1565
DELISTED
Bitcoin Depot
BTM
$50K ﹤0.01%
+3,953
New +$51.1K
HOUS
1566
DELISTED
Anywhere Real Estate
HOUS
$41K ﹤0.01%
+12,258
New +$57.3K
WHWK
1567
Whitehawk Therapeutics
WHWK
$235M
$40K ﹤0.01%
+27,489
New +$50.9K
CXDO icon
1568
Crexendo
CXDO
$222M
$39K ﹤0.01%
+12,459
New +$48.5K
WRAP icon
1569
Wrap Technologies
WRAP
$104M
$38K ﹤0.01%
+18,829
New +$32.7K
LYEL icon
1570
Lyell Immunopharma
LYEL
$360M
$37K ﹤0.01%
1,281
-428
-25% -$20.4K
VERI icon
1571
Veritone
VERI
$122M
$37K ﹤0.01%
+16,464
New +$58.4K
KLRS
1572
Kalaris Therapeutics
KLRS
$96.8M
$37K ﹤0.01%
2,227
-7,626
-77% -$135K
EAF icon
1573
GrafTech
EAF
$212M
$34K ﹤0.01%
+3,476
New +$53.4K
IVVD icon
1574
Invivyd
IVVD
$218M
$27K ﹤0.01%
+24,744
New +$54.7K
EOSE icon
1575
Eos Energy Enterprises
EOSE
$1.51B
$25K ﹤0.01%
+19,787
New +$16.4K
61 62
63
64 65

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.